Hikma at a glance
Discover what drives us
Latest news
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results 22 February 2024
- Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg Press Release, Product 14 January 2025 Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg
- Hikma launches Meropenem for Injection, USP in the US Press Release, Product 14 January 2025 Hikma launches Meropenem for Injection, USP in the US
- Hikma to present at 43rd Annual J.P. Morgan Healthcare Conference Press Release, Corporate 13 January 2025 Hikma to present at 43rd Annual J.P. Morgan Healthcare Conference
- Hikma launches ePHEDrine Sulfate Injection, USP in the US Press Release, Product 30 December 2024 Hikma launches ePHEDrine Sulfate Injection, USP in the US